BioNTech Research & Development, Inc. clinical trials
A subsidiary of BioNTech SE
The registry lists 3 studies whose lead sponsor is BioNTech Research & Development, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 28, 2025.
Registry sponsor names on this page
- BioNTech Research & Development, Inc.3 studies
Something wrong with this grouping? Tell us on the BioNTech SE page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All BioNTech SE studies →
- Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive MalignanciesTerminatedNCT02672917Phase 1
Sponsor listed in the registry: BioNTech Research & Development, Inc.
- Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as RadioimmunotherapyTerminatedNCT03118349Phase 1
Sponsor listed in the registry: BioNTech Research & Development, Inc.
- Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1TerminatedNCT02687230Phase 1
Sponsor listed in the registry: BioNTech Research & Development, Inc.